Guidance
Frequently asked questions and considerations for the introduction of hexavalent vaccine DTwP-HepB-Hib-IPV in routine immunization programmes (June 2024)
This document is targeted primarily to countries currently using pentavalent and inactivated polio vaccine (IPV) schedules. This information is also applicable to countries planning to switch from acellular pertussis combination vaccines to the newly prequalified DTwP-HepB-Hib-IPV hexavalent vaccine
Languages
- English
Publication year
2024
Type
Guidance
Categories
- Programme management
Diseases
- Diphtheria
- Haemophilus influenzae
- Hepatitis B
- HIB
- Pertussis
- Polio
- Tetanus
Organisations
- United Nations Children's Fund (UNICEF)
- World Health Organization (WHO)
Tags
- IPV
- New vaccine introduction
Topic references
PORTFOLIO-HEXAVALENT
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Foire aux questions et éléments à prendre en considération pour l’introduction du vaccin hexavalent (DTwP-HepB-Hib-VPI) dans programmes de vaccination essentiels | World Health Organization (WHO) | 2024 | Guidance | French |
| Frequently asked questions and considerations for the introduction of hexavalent vaccine DTwP-HepB-Hib-IPV in routine immunization programmes (June 2024) | World Health Organization (WHO), UNICEF | 2024 | Guidance | English |
| Perguntas frequentes e considerações para a introdução da vacina hexavalente (DTwP-HepB-Hib-IPV) em programas essenciais de vacinação | World Health Organization (WHO) | 2024 | Guidance | Portuguese |
